| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7M | — | +9364.1% |
| Cost of Revenue | $4.4M | — | — |
| Gross Profit | -$721K | — | -5646.2% |
| R&D Expense | $7.0M | — | +133.5% |
| SG&A Expense | $11.3M | — | +142.6% |
| Operating Income | -$20.6M | — | -148.0% |
| Interest Expense | $171K | — | +194.8% |
| Pre-tax Income | -$4.0M | — | -123.8% |
| Net Income | -$4.0M | — | -123.8% |
| EPS (Basic) | -$0.02 | — | -115.4% |
| EPS (Diluted) | -$0.02 | — | -118.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $257.7M | -65.1% | +54.8% |
| Short-term Investments | $728.4M | +92.0% | — |
| Accounts Receivable | $4.3M | +724.9% | — |
| Inventory | $4.1M | +1068.2% | +3038.9% |
| Current Assets | $1.01B | -11.3% | +501.0% |
| Total Assets | $1.62B | +0.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.4M | — | -112.7% |
| Capital Expenditures | $1.8M | — | +5.1% |
| Investing Cash Flow | -$474.3M | — | — |
| Financing Cash Flow | $3.5M | — | -96.3% |
| Free Cash Flow | -$11.2M | — | -82.4% |
| +568.2% |
| Current Liabilities | $15.1M | +36.1% | +302.9% |
| Total Liabilities | $23.4M | +13.0% | +7.6% |
| Stockholders' Equity | $1.60B | -0.1% | +623.3% |